National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award (CCITLA) P30 Administrative Supplement for Fiscal Year (FY) 2021

美国国家癌症研究所 (NCI) 癌症临床研究者团队领导奖 (CCITLA) P30 2021 财年 (FY) 行政补充文件

• 批准号: 10328184
• 负责人: BEN H PARK
• 金额: $ 6万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-09-01 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10328184
• 关键词: Academic Medical Centers; Address; Administrative Supplement; Antineoplastic Agents; Arts; Award; Basic Science; Cancer Burden; Cancer Center; Cancer Center Support Grant; Cancer Control; Cancer Grant Supplements (P30); Cancer Patient; Caring; Catchment Area; Cell Proliferation; Cessation of life; Clinical; Clinical Investigator; Clinical Research; Collaborations; Communities; Community Outreach; Diagnosis; Discipline of Nursing; Early Diagnosis; Education; Education and Outreach; Engineering; Evaluation; Evidence based intervention; Faculty; Funding; Future; Genome; Genomics; Geography; Grant; Growth; Health; Informatics; Infrastructure; Intervention; Investments; Lead; Leadership; Maintenance; Malignant Neoplasms; Malignant neoplasm of gastrointestinal tract; Medical center; Medicine; Mission; Modeling; NCI Center for Cancer Research; National Cancer Institute; National Cancer Program; Oncology; Organization administrative structures; Outcome; Patient Care; Patient-Centered Care; Patients; Peer Review; Population Research; Postdoctoral Fellow; Practice Guidelines; Prevention; Prevention education; Research; Research Activity; Research Personnel; Research Training; Resource Sharing; Resources; Schools; Science; Signal Transduction; Strategic Planning; Technology; Training; Translating; Translational Research; Translations; United States Department of Veterans Affairs; United States National Institutes of Health; Universities; Work; anticancer research; base; cancer care; cancer epidemiology; cancer health disparity; cancer prevention; cancer therapy; care providers; career; clinical investigation; clinical practice; community engagement; disorder control; disparity reduction; drug discovery; evidence base; graduate student; health equity; host neoplasm interaction; innovation; malignant breast neoplasm; medical schools; member; multidisciplinary; next generation; precision oncology; programs; racial and ethnic; recruit; research facility; socioeconomics; success

VANDERBILT-INGRAM CANCER CENTER OVERALL PROJECT SUMMARY/ABSTRACT This is the fifth competing renewal of the Cancer Center Support Grant (CCSG) at Vanderbilt-Ingram Cancer Center (VICC). VICC is a matrix center within Vanderbilt University Medical Center and Vanderbilt University that integrates the cancer-related expertise and resources of the Schools of Medicine, Nursing, Arts and Sciences and Engineering, the Peabody School of Education and the fully integrated Veterans Administration Medical Center. The major clinical facilities and the majority of research facilities are located on one campus, which promotes informal interactions, sharing of resources and productive collaborations. Established in 1993, VICC functions as an organizational unit with a supra-departmental status. VICC-specific responsibilities and aims are 1) to conduct, support and enhance state-of-the-art, multidisciplinary basic, clinical and population- based research; 2) to coordinate and integrate cancer-related activities across Vanderbilt and to collaborate with our local, regional, national and global partners; 3) to train and develop the next generation of cancer investigators, cancer leaders and the continuum of cancer care providers; and 4) to assess and prioritize community needs and to leverage partnerships to address those needs through cancer research, care and control activities. The research, training, and community outreach and engagement objectives are accomplished through CCSG and institutionally supported organizational capabilities, planning and evaluation, and eight research programs. The VICC Research Programs are Signal Transduction and Cell Proliferation, Genome Maintenance, Host-Tumor Interactions, Gastrointestinal Cancer, Translational Research and Interventional Oncology, Breast Cancer, Cancer Epidemiology, and Cancer Health Outcomes and Control. Eleven shared resources are proposed, all previously supported. Remarkable VICC growth and scientific discovery over the past project period has led to 22 new multi-investigator grants for a total of 71, and 8 new training grants for a total of 26. In addition, two NCI SPOREs were successfully renewed. With these and many other NCI grants, peer-reviewed funding increased 35%. Significant accomplishments have been made in precision oncology, cancer epidemiology, health outcomes and control, genomics, cancer drug discovery, early detection and prevention, and cancer disparities research. Increased VICC space and facilities, along with philanthropic and institutional funds, supported the recruitment of 67 new faculty, who join a dedicated team carrying out the VICC mission: to alleviate cancer death and suffering through pioneering research; innovative patient-centered care; and evidence-based prevention, education and community initiatives. VICC senior leadership provides effective oversight and catalyzes innovative and paradigm-shifting science that translates to benefit for our patients and the community we serve in our catchment and reduces the burden of cancer nationally and globally.

范德比尔特 - 伊格兰癌症中心总体 项目摘要/摘要 这是Vanderbilt-Ingram Cancer的癌症中心支持补助金（CCSG）的第五次竞争续约 中心（VICC）。 VICC是范德比尔特大学医学中心和范德比尔特大学的矩阵中心 这整合了医学，护理，艺术学院与癌症相关的专业知识和资源 科学与工程学，皮博迪教育学院和完全融合的退伍军人管理 医疗中心。主要的临床设施和大多数研究设施都位于一个校园中 促进非正式互动，共享资源和生产性合作。成立于1993年， VICC充当具有超部门状态的组织单位。 VICC特定的责任和 目的是1）进行，支持和增强最先进的，多学科的基本，临床和人群 基于研究； 2）协调和整合范德比尔特各地癌症相关的活动，并与 我们的地方，地区，国家和全球合作伙伴； 3）训练和发展下一代癌症 研究人员，癌症领导者和癌症护理提供者的连续性； 4）评估和优先级 社区需求并利用伙伴关系来通过癌症研究，护理和 控制活动。实现了研究，培训和社区宣传和参与目标 通过CCSG和机构支持的组织能力，计划和评估，八个 研究计划。 VICC研究计划是信号转导和细胞增殖，基因组 维护，宿主肿瘤相互作用，胃肠道癌，转化研究和介入 肿瘤学，乳腺癌，癌症流行病学以及癌症健康结果和对照。十一分享 提出了资源，所有以前都支持。 VICC的显着增长和科学发现 过去的项目期间已获得了22个新的多投资者赠款，总共获得了71份，并获得了8项新的培训补助金 总共26个。此外，成功更新了两个NCI孢子。有了这些以及许多其他NCI赠款， 同行评审的资金增加了35％。精确肿瘤学已经取得了重大成就， 癌症流行病学，健康结果和控制，基因组学，癌症药物发现，早期检测和 预防和癌症差异研究。 VICC空间和设施增加，以及慈善事业和 机构资金支持招募67名新教师，他们加入了一个专门的团队，执行了VICC 任务：通过开拓性研究来减轻癌症的死亡和痛苦；创新的以患者为中心的护理； 以及基于证据的预防，教育和社区计划。 VICC高级领导提供有效 监督和催化创新和范式转移科学，这转化为对我们的患者和 我们在集水区服务的社区，并减轻了全国和全球癌症的负担。